Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (9)
Filtered (9)
Filter

Filter

9 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(9) Reset
Show (9)
Cancel
Apply(9) Reset
9 entriesShowing 1–9
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.
Palladia / Toceranib · Prescription Drug · Targeted Therapy · Palladia · Dogs · After Targeted Therapy · During Targeted Therapy

Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy

Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…

Read more
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.
Laverdia / Verdinexor · Prescription Drug · Targeted Therapy · Laverdia · Dogs · After Targeted Therapy · During Targeted Therapy

Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma

Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Adrenocorticolytic agents · Dogs · During Chemotherapy · New Diagnosis

Mitotane in Canine Adrenal Disease and Adrenocortical Tumours

mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile COP / CVP Lymphoma Chemotherapy: Veterinary Protocol ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · COP / CVP lymphoma protocols · Dogs & Cats · During Chemotherapy · New Diagnosis · Published Study

COP / CVP Lymphoma Chemotherapy: Veterinary Protocol Profile

cyclophosphamide, vincristine (Oncovin) and prednisone or prednisolone is covered as multi-agent lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · MOPP / LOPP lymphoma protocols · Dogs · After Chemotherapy · During Chemotherapy · New Diagnosis

MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols

MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Awake cat monitored by a veterinary oncology team with a closed infusion systemRepresentative category illustration – not the named product or a real patient.
Chemotherapy · Prescription Drug · CMOP feline lymphoma protocol · Cats · During Chemotherapy · New Diagnosis · Limited / Emerging Evidence

Feline CMOP for Intermediate- to Large-Cell Lymphoma

cyclophosphamide, mitoxantrone, vincristine and prednisolone is covered as multi-agent feline lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Awake cat monitored by a veterinary oncology team with a closed infusion systemRepresentative category illustration – not the named product or a real patient.
Chemotherapy · Prescription Drug · Chlorambucil-glucocorticoid feline protocols · Cats · During Chemotherapy · Long-term Management · New Diagnosis

Chlorambucil and Prednisolone for Feline Small-Cell Lymphoma

chlorambucil with prednisolone or another veterinarian-selected glucocorticoid is covered as oral combination chemotherapy for selected feline small-cell lymphoma, with species, evidence, regulatory, safety, interaction and monitoring boundaries for…

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile Melphalan and Prednisone or Prednisolone for Canine Multiple MyelomaRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Melphalan-glucocorticoid myeloma protocols · Dogs · During Chemotherapy · Long-term Management · New Diagnosis

Melphalan and Prednisone or Prednisolone for Canine Multiple Myeloma

melphalan with prednisone or prednisolone is covered as oral alkylator-based protocol for canine multiple myeloma, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile Vinblastine and Prednisone or Prednisolone for Canine Mast Cell TumoursRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Vinblastine-glucocorticoid mast-cell-tumour protocols · Dogs · After Surgery · During Chemotherapy · Long-term Management

Vinblastine and Prednisone or Prednisolone for Canine Mast Cell Tumours

vinblastine with prednisone or prednisolone is covered as combination chemotherapy for selected canine mast-cell tumours, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more